Establishment Labs stock closed at USD 59.18 on October 16, down 3.55 percent

Published on 10/17/2026 at 19:53 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Stifel set a USD 85.00 target on October 14. Establishment Labs stock closed at USD 59.18 on October 16, down 3.55 percent versus Nasdaq.

Analyst view and upcoming results

Stifel initiated coverage with a USD 85.00 target on October 14, 2026.
Second-quarter 2026 revenue reached USD 67.54 million.
Establishment Labs stock closed at USD 59.18 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 3.55 percent versus the Nasdaq close of October 15, 2026.
Establishment Labs is estimated to report third-quarter 2026 results on November 4, 2026.

ESTA, VGG312491084, Illustration mit AI erstellt.

Stifel initiated coverage of Establishment Labs with a Buy rating and a USD 85.00 price target on October 14, 2026, according to Markets Insider. The target stands 43.63 percent above the Nasdaq price of USD 59.18. Establishment Labs closed at USD 59.18 on Nasdaq on October 16, 2026 at 4:00 p.m. ET, down 3.55 percent versus the Nasdaq close of October 15, 2026.

Stifel target sets a higher bar

The analyst view puts the company against a demanding market expectation after a sharp one-session decline. Stifel analyst Joseph Federico cited growth prospects in breast augmentation and potential market-share gains, according to Markets Insider's October 14 report. The target is denominated in USD, matching the Nasdaq quotation used for the comparison.

Second-quarter revenue reached USD 67.54 million

Establishment Labs reported USD 67.54 million in second-quarter 2026 revenue and a USD 0.39 loss per share, figures listed by MarketBeat. The same page places the next quarterly report on November 4, 2026, before the market opens, with a conference call scheduled for 8:30 a.m. ET.

Price position after October 16

The October 16 close sat within a USD 47.00 to USD 97.59 52-week range. The stock was down 3.55 percent for the session, while its 52-week performance remained positive at 38.20 percent. Trading volume was 293,820 shares against an average of 430,753 shares.

Valuation and November 4 date

Establishment Labs had a market capitalization of USD 1.8 billion as of October 16, 2026. Its trailing price-to-earnings ratio was negative 45.23, and the company had no dividend yield in the latest market snapshot. The November 4 reporting date is an estimate, as MarketBeat states.

Comparison with peers

Establishment Labs (Nasdaq, USD): down 3.55 percent, P/E negative 45.23, market capitalization USD 1.8 billion

Envista Holdings (NYSE, USD): down 2.55 percent, P/E 39.48, market capitalization USD 3.7 billion

DENTSPLY SIRONA (Nasdaq, USD): down 2.94 percent, P/E negative 3.13, market capitalization USD 1.7 billion

The October 16 close

The decline left Establishment Labs below its 50-day moving average of USD 69.75 and its 200-day moving average of USD 72.68, both measured on October 16, 2026. The next scheduled reporting date gives the market a dated checkpoint for the revenue and earnings-per-share trajectory.